Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) was already on the radar screens in biotech before this morning. But news showing that the company’s cancer drug carfilzomib has received favorable FDA panel vote has shares surging. …
Celgene Corporation (NASDAQ: CELG) is supposed to be one of the more promising biotechs out there. After all it was worth some $29.6 billion in market capitalization at Wednesday’s close. Now shares are down…
Despite improvements in treatments for the sick and injured, discoveries of new and often more effective drugs, and more hospital facilities that claim to be state of the art, uninsured Americans have been victims of…
PDL BioPharma, Inc. (NASDAQ: PDLI) appears to have a new royalty stream coming its way. The company announced this morning that it is now set to start receiving royalty payments from Roche’s Genentech unit…
We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today. Shares are up nearly 5% at $8.25 and the 12:30 PM trading volume is now over…
To say that Centene Corp. (NYSE: CNC), a managed health care provider, has been on a roller coaster ride for the past few days may be an understatement. First, it and Molina Healthcare Inc.…
Rite Aid Corp. (NYSE: RAD) has been a troubled stock in a difficult financial position for over a decade now. So, it tends to stand out when research firms act very positively on it. …
Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the price appears to be more finite. We have heard enough names around this diabetes…
Late last Friday, Walgreen Co. (NYSE: WAG) issued a brief statement on the company’s dispute with Express Scripts Inc. (NASDAQ: ESRX): The parties have agreed to dismiss their respective claims, and no other action…
Merger and acquisition news has been a bit light of late, but there is at least one deal out there this Monday for M&A watchers to chew over. MEDTOX Scientific, Inc. (NASDAQ: MTOX) has entered…
We have several shares of biotech stocks on the move, but frankly the news from th American Society of Clinical Oncology, or ASCO, looks a bit muted. So far these are the winners and…
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was very close to 52-week highs of late, but that will not be the case now. The company updated information that is being called a correction about lung function from…
AuthorDendreon Corporation (NASDAQ: DNDN) needs all the goods news it can get. While the American Society for Clinical Oncology (ASCO) has its annual meeting in les than two weeks and while that is expected…
DaVita Inc. (NYSE: DVA) is facing a bit of a drag on its announcement that it is spending some $4.4 billion to acquire HealthCare Partners. This is a transformative deal because DaVita is the…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take…